Downregulation of ACSL4 induced by the synergistic therapy of aspirin and sorafenib significantly weakened cell tumorigenesis and induced cell apoptosis in HCC Hep3B and HuH-7 cells [28]. This evidence concerns the gene ACSL4 and hepatocellular carcinoma.